Welcome
Support Centre
12 March 2010 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
A Randomised Trial Comparing the Efficacy of Intraperitoneal Drainage With or Without Intraperitoneal Cisplatin for Malignant Ascites in Gastrointestinal Cancer
ISRCTN ISRCTN84631770
ClinicalTrials.gov identifier
Public title A Randomised Trial Comparing the Efficacy of Intraperitoneal Drainage With or Without Intraperitoneal Cisplatin for Malignant Ascites in Gastrointestinal Cancer
Scientific title
Acronym N/A
Serial number at source IPCISPLATIN
Study hypothesis Not provided at time of registration
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Cancer of Duodenum, Stomach
Participants - inclusion criteria 1. Histologically verified locally advanced or metastatic adenocarcinoma of the gastrointestinal tract
2. Clinically confirmed symptomatic ascites
3. Glomerular filtrate rate of >40ml/min
4. Patients must not have received intraperitoneal cisplatin before
5. No concurrent intravenous cisplatin, and at least a 2 week gap after the completion of intravenous cisplatin before intraperitoneal therapy can be commenced
6. Intravenous chemotherapy (except cisplatin) may be given concurrently
7. No medical contraindications to treatment
Participants - exclusion criteria Not provided at time of registration
Anticipated start date 01/01/1996
Anticipated end date 31/03/2001
Status of trial Completed
Patient information material
Target number of participants Not provided at time of registration
Interventions 1. Group A: Intraperitoneal drainage only
2. Group B: Intraperitoneal drainage plus intraperitoneal cisplatin
Primary outcome measure(s) Not provided at time of registration
Secondary outcome measure(s) Not provided at time of registration
Sources of funding Royal Marsden Hospital (UK)
Trial website
Publications
Contact name Dr  -  -
  Address UKCCCR Register Co-ordinator
MRC Clinical Trials Unit
222 Euston Road
  City/town London
  Zip/Postcode NW1 2DA
  Country United Kingdom
  Tel +44 (0) 20 7670 4723
  Fax +44 (0) 20 7670 4818
  Email register@ctu.mrc.ac.uk
Sponsor The Royal Marsden NHS Foundation Trust (UK)
  Address Downs Road
  City/town Sutton
  Zip/Postcode SM2 5PT
  Country United Kingdom
Date applied 19/08/2002
Last edited 29/05/2008
Date ISRCTN assigned 19/08/2002
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© ISRCTN


BioMed Central